Elisabeth Leiderman
2022
In 2022, Elisabeth Leiderman earned a total compensation of $751.9K as Former Chief Financial Officer and Head of Corporate Development at Decibel Therapeutics, a 32% increase compared to previous year.
Compensation breakdown
| Option Awards | $137,004 |
|---|---|
| Salary | $307,692 |
| Other | $307,239 |
| Total | $751,936 |
Leiderman received $307.7K in salary, accounting for 41% of the total pay in 2022.
Leiderman also received $137K in option awards and $307.2K in other compensation.
Rankings
In 2022, Elisabeth Leiderman's compensation ranked 3,598th out of 5,625 executives tracked by ExecPay. In other words, Leiderman earned more than 36.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,598 out of 5,625 | 36th |
Division Manufacturing | 2,042 out of 3,053 | 33rd |
Major group Chemicals And Allied Products | 976 out of 1,380 | 29th |
Industry group Drugs | 913 out of 1,281 | 29th |
Industry Pharmaceutical Preparations | 663 out of 927 | 29th |
Source: SEC filing on April 28, 2023.
Leiderman's colleagues
We found three more compensation records of executives who worked with Elisabeth Leiderman at Decibel Therapeutics in 2022.